Abstract Finding effective and objective biomarkers to inform the diagnosis of schizophrenia is of great importance yet remains challenging. Relatively little work has been conducted on multi-biological data for the diagnosis of schizophrenia. In this cross-sectional study, we extracted multiple features from three types of biological data, including gut microbiota data, blood data, and electroencephalogram data. Then, an integrated framework of machine learning consisting of five classifiers, three feature selection algorithms, and four cross validation methods was used to discriminate patients with schizophrenia from healthy controls. Our results show that the support vector machine classifier without feature selection using the input fea...
Schizophrenia is a severe mental disorder and one of the leading causes of disease burden worldwide....
The emergence of machine learning (ML) techniques has opened up new avenues for identifying biomarke...
This paper aims to apply machine learning methods to analyze the biomarkers of symptoms in patients ...
Utilizing neuroimaging and machine learning (ML) to differentiate schizophrenia (SZ) patients from n...
Background: Schizophrenia risk is associated with genetic variation and with early life environmenta...
There is mounting evidence indicating a relation- ship between the gut microbiome composition and th...
In this paper, we use the promising paradigm of Multiple Kernel Learning (MKL) to challenge the prob...
In recent years, machine learning approaches have been successfully applied for analysis of neuroima...
Machine learning models have been successfully employed in the diagnosis of Schizophrenia disease. T...
Schizophrenia is a severe psychiatric disorder associated with both structural and functional brain ...
Schizophrenia (SZ) is a mental heterogeneous psychiatric disorder with unknown cause. Neuroscientist...
Schizophrenia, as a psychiatric disorder, has recognized brain alterations both at the structural an...
The emergence of machine learning (ML) techniques has opened up new avenues for identifying biomarke...
Schizophrenia is a severe mental disorder and one of the leading causes of disease burden worldwide....
Schizophrenia, as a psychiatric disorder, has recognized brain alterations both at the structural an...
Schizophrenia is a severe mental disorder and one of the leading causes of disease burden worldwide....
The emergence of machine learning (ML) techniques has opened up new avenues for identifying biomarke...
This paper aims to apply machine learning methods to analyze the biomarkers of symptoms in patients ...
Utilizing neuroimaging and machine learning (ML) to differentiate schizophrenia (SZ) patients from n...
Background: Schizophrenia risk is associated with genetic variation and with early life environmenta...
There is mounting evidence indicating a relation- ship between the gut microbiome composition and th...
In this paper, we use the promising paradigm of Multiple Kernel Learning (MKL) to challenge the prob...
In recent years, machine learning approaches have been successfully applied for analysis of neuroima...
Machine learning models have been successfully employed in the diagnosis of Schizophrenia disease. T...
Schizophrenia is a severe psychiatric disorder associated with both structural and functional brain ...
Schizophrenia (SZ) is a mental heterogeneous psychiatric disorder with unknown cause. Neuroscientist...
Schizophrenia, as a psychiatric disorder, has recognized brain alterations both at the structural an...
The emergence of machine learning (ML) techniques has opened up new avenues for identifying biomarke...
Schizophrenia is a severe mental disorder and one of the leading causes of disease burden worldwide....
Schizophrenia, as a psychiatric disorder, has recognized brain alterations both at the structural an...
Schizophrenia is a severe mental disorder and one of the leading causes of disease burden worldwide....
The emergence of machine learning (ML) techniques has opened up new avenues for identifying biomarke...
This paper aims to apply machine learning methods to analyze the biomarkers of symptoms in patients ...